Cure raises €1.4 million

Fintech Cure wants to make everyday life easier for doctors' surgeries financially. The start-up is competing with Apobank.

The start-up Cure Finance, founded in 2020, has completed its first financing round with 1.4 million euros. The round was led by VR Ventures, a fund financed by various Volksbanks. Two family offices from Switzerland and Austria, as well as a number of doctors and dentists, are also among the backers.

Cure intends to invest the money in the development of new financial products for the medical professions. The Cure Dashboard, a portal that compiles financial data from the company's bank account and practice at a glance, is to be launched this year. One year later, in 2022, Cure wants to offer medical practices their own business account with a credit card and present financing solutions for practice start-ups.

Cure's aim is to create a platform for medical practices on which banking, controlling, accounting and taxes can be managed in a standardized way. Practices will be able to manage their bank accounts and practice systems via a single platform.

Timo Fleig from VR-Ventures is, according to reports from start-up scene that Cure will be successful with its approach: "The experienced founding team has fully convinced us in this early project phase and we believe in a successful market entry of the Cure platform."